Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • AMYLIN PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: AMLN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 3.143 Hold 14
    30 Days Ago 3.133 Hold 15
    60 Days Ago 3.059 Hold 17
    90 Days Ago 3.059 Hold 17
    120 Days Ago 3.059 Hold 17

  • Analyst Ratings: AMLN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    FTN Equity Capital — Neutral 04/28/2009 —
    Leerink Swann Outperform Mkt Perform 04/07/2009 8.50
    Canaccord Adams Hold Sell 01/28/2009 —
    Barclays Capital — Equal Weight 10/22/2008 13.00
    Canaccord Adams Sell Hold 10/07/2008 —
    Citigroup Sell Hold 10/05/2008 17.00
    Leerink Swann — Outperform 10/03/2008 34.00
    Collins Stewart — Hold 09/26/2008 —
    Lazard Capital Hold Buy 09/02/2008 —
    Canaccord Adams — Sell 08/27/2008 20.00
    Lehman Brothers — Equal-Weight 08/27/2008 23.00
    Robert W. Baird Outperform Neutral 08/27/2008 27.00
    Soleil Hold Sell 08/27/2008 —
    Leerink Swann — Outperform 08/25/2008 —
    Stanford Research Buy Hold 08/19/2008 33.00
    Friedman Billings Outperform — 07/10/2008 —
    Friedman Billings Outperform — 06/30/2008 —
    Jefferies & Co Buy Hold 06/09/2008 33.00
    Lehman Brothers Underweight Equal-Weight 05/28/2008 31.00
    BMO Capital Markets Market Perform Underperform 04/22/2008 —
    Lehman Brothers — Underperform 04/22/2008 23.00
    Lazard Capital Buy Hold 03/03/2008 —
    Canaccord Adams — Sell 02/12/2008 —
    Stanford Research — Buy 01/29/2008 49.00
    Lazard Capital — Buy 01/29/2008 57.00
    BMO Capital Markets — Market Perform 01/29/2008 34.00
    Friedman Billings — Outperform 01/29/2008 43.00
    Robert W. Baird — Outperform 01/15/2008 47.00
    Friedman Billings — Outperform 01/04/2008 46.00
    Friedman Billings — Outperform 11/29/2007 58.00
    Next